Cavernous Nerves: Function, Damage, and Recovery

Cavernous nerves are small autonomic nerve fibers that travel alongside the prostate and urethra, carrying the signals responsible for penile erection. When they work properly, you never think about them. When they are damaged, the consequences are immediate and distressing: erectile dysfunction that can last months or years, or become permanent. The story of these nerves, from the discovery that made nerve-sparing surgery possible to the experimental therapies that may one day repair them, is one of the more consequential chapters in modern urology.

What Cavernous Nerves Actually Do

The cavernous nerves originate from the pelvic plexus, a web of nerve fibers that sits deep in the pelvis. They run along the posterolateral surface of the prostate before passing through the pelvic floor and entering the penis. Anatomical dissection studies have shown that the nerves split into medial branches that follow the urethra and lateral branches that pierce the pelvic floor muscles about 4 to 7 mm from the external sphincter. At the penile level, the cavernous nerves communicate extensively with the dorsal nerve of the penis, suggesting the two nerve systems share pathways to reach the erectile tissue.

Their primary job is triggering and sustaining erection. When sexually aroused, the brain and spinal cord send signals down the cavernous nerves, which release nitric oxide (NO) at their terminals inside the erectile tissue. Nitric oxide relaxes the smooth muscle in the walls of the penile blood vessels and the spongy chambers called the corpora cavernosa. Blood rushes in, the chambers expand, veins get compressed against surrounding tissue, and the result is an erection.

For years, researchers assumed the cavernous nerves only initiated erection and that a different chemical mechanism maintained it. That turns out to be wrong. Work in animal models demonstrated that the enzyme producing NO in these nerves, neuronal nitric oxide synthase (nNOS), is involved in both starting and sustaining an erection. Blocking nNOS pharmacologically or knocking it out genetically prevented sustained erections, even when other pathways were chemically stimulated.¹ This means cavernous nerve health is not just important for getting an erection going but for keeping it going long enough for intercourse.

How Cavernous Nerves Get Damaged

The most common and well-studied cause of cavernous nerve injury is radical prostatectomy, the surgical removal of the prostate for cancer. The nerves run so close to the prostate capsule that removing the gland without touching them is extremely difficult. Even when a surgeon deliberately tries to preserve them, stretching, compression, or thermal injury from surgical instruments can impair function. Studies estimate that cavernous nerve injury during prostate cancer surgery and other pelvic operations causes erectile dysfunction in more than 80% of patients.²

Radiation therapy for prostate cancer also damages the cavernous nerves. Radiation reduces motor function in the nerve fibers and may cause axonal degeneration over time, contributing to erectile dysfunction that tends to develop gradually rather than appearing immediately after treatment.³ Other pelvic surgeries, including rectal cancer operations and some bladder procedures, can also injure the cavernous nerves because these nerves pass through the same crowded anatomical corridor.

What Happens Inside the Penis After Nerve Injury

The damage does not stop at the nerve. When the cavernous nerves stop sending signals, the erectile tissue enters what researchers describe as a persistent state of reduced blood flow and low oxygen. Without the regular influx of oxygenated blood that erections provide (including the involuntary nighttime erections healthy men experience during sleep), the smooth muscle cells in the corpora cavernosa begin to die off. Scar-like fibrous tissue gradually replaces the elastic smooth muscle.⁴ This fibrosis changes the structure of the erectile chambers, making them less able to trap blood even if nerve signals eventually return. It is a use-it-or-lose-it problem at the tissue level, which is a major reason why early rehabilitation matters.

An interesting diagnostic clue comes from studies of men who have undergone pelvic surgery. Nocturnal erections, the spontaneous ones that happen during REM sleep, are diminished but not completely eliminated after surgical dissection in many patients. This suggests that even when erectile dysfunction is severe, some cavernous nerve fibers often survive. The nerve lesion is usually partial rather than total, which helps explain why medications like sildenafil (Viagra) work surprisingly well in many post-surgical patients.⁵

Nerve-Sparing Surgery and Its Results

The first intentional nerve-sparing radical prostatectomy was performed on April 26, 1982, after anatomical research finally mapped the precise course of the cavernous nerves relative to the prostate. The patient regained normal sexual function within a year of surgery and maintained both cancer control and quality of life for decades afterward.⁶ That procedure transformed prostate cancer surgery and remains the standard approach for men who are candidates.

Recovery rates depend heavily on whether the surgeon can spare the nerve bundles on one or both sides. In one study of robotic-assisted prostatectomy with a novel technique preserving the tissue layer surrounding the nerves, men who had both nerve bundles spared achieved satisfactory erectile function at rates that climbed steadily over the first year: about 47% at one month, 73% at three months, 84% at six months, and 88% at twelve months. For men with only one side spared, the figures were lower at each time point but still reached 80% at one year.⁷

Other surgical series show broadly consistent trends, though outcomes vary with surgical technique and patient characteristics. An earlier study of robotic nerve-sparing surgery reported potency return at 12 months of about 87% for bilateral sparing and 87% for unilateral sparing, with much lower early recovery rates in the unilateral group.⁸ When tumor extent forced a “semi-sparing” approach on both sides (preserving some but not all of each bundle), only about half of patients recovered potency by one year. A separate study focused on unilateral nerve sparing found that about 30% of men regained full potency, with the vast majority of those recoveries happening within 18 months. Age was the single most important predictor of who recovered and who did not.⁹

Intraoperative Nerve Monitoring

One challenge of nerve-sparing surgery is that the cavernous nerves are not always visible. They are small, often embedded in fatty tissue, and their exact path varies between patients. Several research teams have developed techniques to electrically stimulate the nerves during surgery and monitor the penile response in real time, helping the surgeon know whether the nerve is intact and where it lies.

In early clinical experience with one such device, 94% of patients who showed a positive tumescence response during intraoperative stimulation reported being able to have erections after surgery.¹⁰ Another approach measured pressure changes inside the erectile tissue directly. In that study, patients whose nerves produced a strong pressure response during stimulation all reported erections sufficient for intercourse afterward, while those with weak responses had much poorer outcomes.¹¹ These monitoring techniques remain more common in academic centers than in routine practice, though the idea of giving surgeons live feedback on nerve integrity continues to be refined.¹²

Recovery Timeline and Natural Regeneration

Natural recovery of erections after radical prostatectomy can take 18 to 24 months, even when the nerves were spared.¹³ That long window reflects the slow pace of peripheral nerve regeneration. When a nerve is stretched or compressed but not completely severed, the outer structure may remain intact while the internal signal-carrying fibers need time to heal, a process called neuropraxia. When the nerve is actually cut, recovery depends on whether new fibers can grow back to their targets.

Animal research gives a clearer picture of what regeneration looks like at the cellular level. In a rat model where the cavernous nerve was cut on one side only, the number of nerve fibers that produce nitric oxide dropped sharply on the injured side within three weeks. By six months, however, the number had recovered significantly and approached the level of the uninjured side. When the nerve was cut on both sides, the fibers decreased and stayed low at six months, and no erectile response could be produced by nerve stimulation.¹⁴ The takeaway: when at least one nerve bundle survives, significant regeneration is possible over time. When both are destroyed, spontaneous recovery is unlikely.

Penile Rehabilitation with Medications

The rationale behind penile rehabilitation is simple: keep blood flowing to the erectile tissue during the months-long wait for nerves to recover, preventing the fibrosis and smooth muscle loss described earlier. The most widely used approach involves PDE5 inhibitors, the same class of drugs as sildenafil and tadalafil.

A prospective randomized trial comparing early versus delayed sildenafil use after robotic prostatectomy found that starting medication immediately after surgery made a substantial difference. By 12 months, about 41% of men in the early-start group had achieved full erectile recovery, compared to about 18% in the delayed group. Early use was the only factor that independently predicted better recovery at one year.¹⁵

A larger body of evidence supports daily tadalafil in particular. The REACTT trial, one of the most cited studies in this area, found that daily tadalafil was more effective than on-demand use or placebo for drug-assisted erectile function after bilateral nerve-sparing surgery, and also significantly reduced loss of penile length. However, a complicating finding emerged across multiple studies: when patients stopped taking PDE5 inhibitors during a washout period, the improvements in unassisted (drug-free) erectile function largely disappeared.¹⁶ A meta-analysis confirmed this pattern: PDE5 inhibitors clearly improve erectile response while you are taking them, but do not appear to produce lasting spontaneous recovery after discontinuation.¹⁷

This is one of the more honest-but-frustrating findings in the field. PDE5 inhibitors are the standard of care, and for good reason: they help maintain tissue health and allow sexual activity during recovery. But framing them as a cure that restores natural function overstates the evidence. For many men, continued medication use becomes the long-term reality.

Experimental Approaches to Nerve Repair

When cavernous nerves are partially or fully severed rather than merely bruised, the research frontier shifts to strategies aimed at actively regrowing them. Several approaches have shown promise in animal models, though human clinical data remain limited.

Nerve Grafts and Conduits

When a segment of cavernous nerve is missing, bridging the gap with a graft can guide regrowing nerve fibers to their target. Rat studies have tested autologous vein grafts (using a piece of the animal’s own vein as a tube) and found that they support regeneration, with the addition of growth factors further boosting axon regrowth and erectile pressure recovery.¹⁸ Biodegradable synthetic conduits filled with collagen sponge have also worked in rats, facilitating nerve fiber sprouting and functional recovery.¹⁹

The most impressive conduit results so far have come from tubes seeded with Schwann cells, the support cells that normally wrap around nerve fibers and help them regenerate. In one study, conduits seeded with Schwann cells engineered to produce a nerve growth factor called GDNF restored erections in 94% of rats, significantly outperforming traditional autologous nerve grafts, which succeeded in only 25%.²⁰ These are animal numbers, and the gap between a rat study and a human treatment is wide, but the principle that engineered nerve conduits can outperform natural grafts is encouraging.

Stem Cells

Stem cell therapy for cavernous nerve injury has accumulated enough animal data to support a formal meta-analysis. Pooling results across studies, stem cell transplantation produced a significant improvement in erectile function compared to untreated controls.²¹ Fat-derived stem cells (adipose tissue-derived stem cells, or ADSCs) are among the most studied types. In one rat study, both whole stem cells and their lysate (the contents released when the cells are broken open) improved erectile recovery. The mechanism appeared to involve preserving the nerve fibers that produce nitric oxide while also reducing cell death and fibrosis in the penile tissue.²² The finding that cell-free lysate worked nearly as well as live cells is interesting because it suggests stem cells may help primarily by releasing protective molecules rather than by physically integrating into the nerve.

Growth Factors and Gene Therapy

Two growth factors keep appearing in cavernous nerve research: brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF). Both have independently promoted nerve regeneration in rat models, and combined delivery through engineered scaffolds enhanced the effect beyond what either achieved alone.²³ One scaffold study found that the sequence of delivery mattered: releasing VEGF first (to stimulate blood vessel formation) followed by BDNF (to support nerve growth) produced better results than the reverse order.²⁴

Gene therapy takes this a step further by delivering genetic instructions that cause the body’s own cells to produce these helpful proteins. Strategies that boost nitric oxide production, growth factor signaling, or ion channel activity in smooth muscle have all been explored as potential treatments for erectile dysfunction, though none has advanced to widespread clinical use.²⁵

Shockwave Therapy and Electrical Stimulation

Low-intensity extracorporeal shockwave therapy (Li-ESWT) has attracted attention as a non-invasive option. The idea is that targeted mechanical energy promotes nerve regeneration by increasing growth factor levels, activating Schwann cells, and stimulating cell division in damaged tissue.²⁶ In a rat model, combining shockwave therapy applied to the penile tissue with stem cells applied to the cavernous nerve produced improvements in smooth muscle content, nitric oxide synthase levels, and endothelial markers that were significantly greater than either treatment alone.²⁷

Low-intensity electrical stimulation of the cavernous nerve itself has also shown benefit in animals. In a rat model of bilateral nerve injury, electrical stimulation normalized the number of nerve cells producing nitric oxide and reduced the rate of cell death in the dorsal penile nerve.²⁸ Hyperbaric oxygen therapy has been explored along similar lines, with one rat study reporting improved erectile function preservation after nerve injury, likely mediated by maintaining growth factor and endothelial signaling in penile tissue.²⁹ All of these adjunct therapies remain largely experimental, but the consistent theme across them is encouraging: the cavernous nerve, like many peripheral nerves, is capable of regeneration when given the right biological support.

Cavernous Nerves in Women

Though nearly all cavernous nerve research focuses on men, women have analogous autonomic nerve fibers. In female cadaveric dissections, the cavernous nerves were found to originate from the vaginal nerve plexus, running along the anterolateral wall of the vagina before traveling along the urethra to reach the clitoris.³⁰ These nerves play a role in clitoral engorgement and genital arousal, the female counterpart to penile erection.

A recent immunohistochemical study of adult female cadavers found that the highest density of both somatic and autonomic nerve fibers in the clitoris was concentrated in a well-defined region above the clitoral body. The authors emphasized that surgical preservation of this area is critical for maintaining nerve supply to the clitoris.³¹ Pelvic surgeries in women, including radical hysterectomy for cervical cancer, carry a risk of damaging these nerves, potentially affecting sexual function. Awareness of female cavernous nerve anatomy is growing but still lags far behind the male counterpart, both in surgical technique refinements and in rehabilitation research.